SG Americas Securities
PEAR

SG Americas Securities’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

SG Americas Securities’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-84,440
Closed -$22K – 3458
2023
Q1 		$22K Buy
84,440
+58,764
+229% +$53.1K ﹤0.01% 3151
2022
Q4 		$30K Buy
25,676
+9,741
+61% +$20.5K ﹤0.01% 2896
2022
Q3 		$33K Buy
+15,935
New +$27K ﹤0.01% 3053

SG Americas Securities's PEAR Position: Q2 2023 in Review

SG Americas Securities sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 84,440 shares — an estimated $22K sold.

SG Americas Securities first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $33K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • SG Americas Securities reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 84,440 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $22K.
  • SG Americas Securities first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • SG Americas Securities's Pear Therapeutics, Inc. Class A Common Stock position peaked at $33K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.